MAHBOOB VASEEM (Chief Financial Officer) received a stock award from KESTRA MEDICAL TECHNOLOGIES, LTD.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/21/2025ACC: 0000950170-25-097321
Officer· Chief Financial Officer
Since Mar 2025
+22.06K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
22.06K acquired
Non-Derivative Transactions1
Common Shares
Direct
Shares
+22.06K
Price / share
—
Trade value
—
% of position
148.7%
7/17/2025
14.84K→36.90K
Total
Net shares
+22.06K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 7/17/2025 | A · Award | +22.06K | — | — | 148.7% | 14.84K | 36.90K |
| Total | +22.06K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)0
No non-derivative holdings reported
Derivative Holdings (Post-Transaction)1
Options
DirectUnderlying security
Common Shares
Underlying shares
159K
Shares owned
159K
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
159K
Owned
159K
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Options Direct | Common Shares | — | — | 159K | 159K | |
| Total | 159K | 159K | ||||